Osimertinib (AZD9291) in Asia-Pacific Patients with T790M Mutation-Positive Advanced NSCLC: Open-Label Phase II Study Results
JOURNAL OF THORACIC ONCOLOGY(2017)
关键词
EGFR-TKI,T790M,osimertinib (AZD9291),EGFR mutation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要